HK1084974A1 - Packaging cells for recombinant adenovirus - Google Patents

Packaging cells for recombinant adenovirus

Info

Publication number
HK1084974A1
HK1084974A1 HK06107148.0A HK06107148A HK1084974A1 HK 1084974 A1 HK1084974 A1 HK 1084974A1 HK 06107148 A HK06107148 A HK 06107148A HK 1084974 A1 HK1084974 A1 HK 1084974A1
Authority
HK
Hong Kong
Prior art keywords
recombinant adenovirus
packaging cells
packaging
cells
adenovirus
Prior art date
Application number
HK06107148.0A
Other languages
English (en)
Inventor
Ronald Vogels
Menzo Jans Emco Havenga
David A T M Zuijdgeest
Original Assignee
Crucell Holland Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Crucell Holland Bv filed Critical Crucell Holland Bv
Publication of HK1084974A1 publication Critical patent/HK1084974A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C12N15/861—Adenoviral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10351—Methods of production or purification of viral material
    • C12N2710/10352—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/38—Vector systems having a special element relevant for transcription being a stuffer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
HK06107148.0A 2003-10-02 2006-06-22 Packaging cells for recombinant adenovirus HK1084974A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP0350679 2003-10-02
PCT/EP2004/052428 WO2005033320A1 (en) 2003-10-02 2004-10-04 Packaging cells for recombinant adenovirus

Publications (1)

Publication Number Publication Date
HK1084974A1 true HK1084974A1 (en) 2006-08-11

Family

ID=34400432

Family Applications (1)

Application Number Title Priority Date Filing Date
HK06107148.0A HK1084974A1 (en) 2003-10-02 2006-06-22 Packaging cells for recombinant adenovirus

Country Status (16)

Country Link
US (2) US7816104B2 (ja)
EP (1) EP1670925B1 (ja)
JP (1) JP4749334B2 (ja)
KR (1) KR101203817B1 (ja)
CN (2) CN1863918B (ja)
AU (1) AU2004278517B2 (ja)
BR (1) BRPI0414670A (ja)
CA (1) CA2538025C (ja)
DK (1) DK1670925T3 (ja)
EA (1) EA010924B1 (ja)
HK (1) HK1084974A1 (ja)
HR (1) HRP20130616T1 (ja)
IL (2) IL174489A (ja)
NZ (1) NZ545501A (ja)
SI (1) SI1670925T1 (ja)
WO (1) WO2005033320A1 (ja)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6492169B1 (en) 1999-05-18 2002-12-10 Crucell Holland, B.V. Complementing cell lines
CN1863918B (zh) 2003-10-02 2011-03-30 克鲁塞尔荷兰公司 用于重组腺病毒的包装细胞
WO2007110409A1 (en) * 2006-03-27 2007-10-04 Crucell Holland B.V. Compositions comprising a recombinant adenovirus and an adjuvant
WO2008134720A2 (en) * 2007-04-30 2008-11-06 Medtronic, Inc. Inert dna sequences for efficient viral packaging and methods of use
ES2532015T3 (es) * 2008-11-03 2015-03-23 Crucell Holland B.V. Método para la producción de vectores adenovíricos
US9404090B2 (en) * 2011-11-24 2016-08-02 Viromed Co., Ltd. Adenovirus producing novel cell line and the use thereof
MX357009B (es) 2011-11-28 2018-06-22 Crucell Holland Bv Vacunas contra el virus de la influenza y sus usos.
MY169352A (en) * 2012-03-22 2019-03-25 Janssen Vaccines & Prevention Bv Vaccine against rsv
EP3613849A4 (en) 2017-04-21 2021-01-06 Geneuin-Tech Co., Ltd. CELL LINE FOR MANUFACTURING NON-REPLICATIVE ADENOVIRUS AND MANUFACTURING METHOD FOR IT
CN108342362A (zh) * 2018-01-31 2018-07-31 武汉枢密脑科学技术有限公司 一种用于扩增重组犬腺病毒cav2的稳定细胞系mdck及其构建方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4889806A (en) * 1987-04-15 1989-12-26 Washington University Large DNA cloning system based on yeast artificial chromosomes
US5610053A (en) 1993-04-07 1997-03-11 The United States Of America As Represented By The Department Of Health And Human Services DNA sequence which acts as a chromatin insulator element to protect expressed genes from cis-acting regulatory sequences in mammalian cells
US5834256A (en) * 1993-06-11 1998-11-10 Cell Genesys, Inc. Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells
US5820868A (en) 1993-12-09 1998-10-13 Veterinary Infectious Disease Organization Recombinant protein production in bovine adenovirus expression vector system
DE69535178T2 (de) 1994-06-10 2006-12-14 Genvec, Inc. Adenoviren-vektor systeme und zelllinien
JPH10509880A (ja) 1994-11-28 1998-09-29 ジェネティック セラピー， インコーポレイテッド 組織特異的複製のためのベクター
AU709498B2 (en) 1994-12-12 1999-09-02 Genetic Therapy, Inc. Improved adenoviral vectors and producer cells
ES2333425T5 (es) * 1995-06-15 2012-08-28 Crucell Holland B.V. Sistemas de empaquetado para adenovirus recombinante humano destinados a terapia génica
SI1533380T1 (sl) 1999-04-15 2010-03-31 Crucell Holland Bv Proizvajanje rekombinantnega proteina v človeški celici ki obsega vsaj en protein E adenovirusa
US6492169B1 (en) * 1999-05-18 2002-12-10 Crucell Holland, B.V. Complementing cell lines
US6558948B1 (en) 1999-11-23 2003-05-06 Stefan Kochanek Permanent amniocytic cell line, its production and use for the production of gene transfer vectors
EP1103610A1 (en) 1999-11-26 2001-05-30 Introgene B.V. Production of vaccines from immortalised mammalian cell lines
BRPI0210771B8 (pt) 2001-07-04 2021-05-25 Chromagenics Bv construção de dna recombinante, método para a produção de um produto de gene em uma célula, e, uso de uma sequência de dna
US20050054105A1 (en) * 2001-10-04 2005-03-10 Volker Sandig Adenoviral vector system
US7026164B2 (en) * 2003-07-03 2006-04-11 Cell Genesys, Inc. Adenovirus packaging cell lines
CN1863918B (zh) 2003-10-02 2011-03-30 克鲁塞尔荷兰公司 用于重组腺病毒的包装细胞

Also Published As

Publication number Publication date
EP1670925B1 (en) 2013-05-01
CN102174536A (zh) 2011-09-07
AU2004278517A1 (en) 2005-04-14
CN1863918A (zh) 2006-11-15
HRP20130616T1 (en) 2013-08-31
US7816104B2 (en) 2010-10-19
AU2004278517B2 (en) 2010-04-01
EA200600693A1 (ru) 2006-10-27
CA2538025A1 (en) 2005-04-14
SI1670925T1 (sl) 2013-10-30
NZ545501A (en) 2010-12-24
CN102174536B (zh) 2013-02-13
US20060183232A1 (en) 2006-08-17
US20100311172A1 (en) 2010-12-09
KR101203817B1 (ko) 2012-11-23
EA010924B1 (ru) 2008-12-30
WO2005033320A1 (en) 2005-04-14
JP4749334B2 (ja) 2011-08-17
IL174489A0 (en) 2006-08-01
IL227543A (en) 2015-08-31
DK1670925T3 (da) 2013-07-08
EP1670925A1 (en) 2006-06-21
CA2538025C (en) 2012-07-17
CN1863918B (zh) 2011-03-30
JP2007507216A (ja) 2007-03-29
US8114637B2 (en) 2012-02-14
BRPI0414670A (pt) 2006-11-21
KR20060095557A (ko) 2006-08-31
IL174489A (en) 2013-10-31

Similar Documents

Publication Publication Date Title
IL227543A (en) Packaging Cells for Adeno Recombinant Virus
SI1597168T1 (sl) EmbalaĹľa
EP1773679A4 (en) PACKAGING
EP1789326B8 (en) Improved package
ZAA200501234S (en) Packages
EP1989528A4 (en) CELL SUPPORT
AU157762S (en) Packaging
AU154593S (en) Package
IL158173A0 (en) Nanopatch-containing cells
CA94975S (en) Egg pack
GB2398554B (en) Package
TW554916U (en) Improved structure for airtight type container
GB0306571D0 (en) Packages
GB0411025D0 (en) Packaging sixteen
GB0321179D0 (en) Adenoviral epitopes
GB0321063D0 (en) Adenoviral epitopes
GB0304453D0 (en) Packaging thirteen
IL145006A0 (en) Transparent pack for etrogim
AU156162S (en) Packaging for snackfood
TW549297U (en) Improved structure for moisture-proof container
GB0308710D0 (en) Package
GB0301474D0 (en) Package
GB0301851D0 (en) Package
AU154594S (en) Package
AU152874S (en) Package

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20211004